Skip to content
  • Thursday, 22 October 2026
  • 7:59 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AbbVie and McLaren Accelerate Into a Multi-Year Partnership as Big Pharma Seeks Global Visibility Through Elite Motorsport
Pharmaceutical R&D

AbbVie and McLaren Accelerate Into a Multi-Year Partnership as Big Pharma Seeks Global Visibility Through Elite Motorsport

Teuku Ryan Oct 21, 2026 0

Biopharmaceutical giant AbbVie has formally accelerated its strategic push into global sports marketing by announcing a multi-year partnership with the…

Read More
Resonant Mie Voids in Bismuth Telluride Enhance Light Emission and Nonlinear Optical Responses in Atomically Thin Tungsten DisulfideData Scientists Evolve into AI System Managers Amidst Generative AI Revolution and Production DemandsUnlocking Cellular Highways: Oregon Researchers Discover Internal "Trade Winds" Revolutionizing Understanding of Cell Movement and DiseaseGinkgo, Tangible and Inductive Bio Launch ADME-One Platform to Revolutionize Early Drug Discovery Decisions with AI and Automation
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Unlocking Precision Genomics: Bio-Rad Releases Comprehensive Guide Bundle on the Evolution and Application of Digital PCRRevolutionary Laser Phase Plate Breakthrough Empowers Electron Microscopes to Image Previously Invisible Cellular Structures and Small Human ProteinsBeyond Telomeres: Penn Medicine Researchers Discover Unexpected Muscle-Repairing Role for Chromosome Protein TRF2The FDA plans its third rare disease policy change in just over a year
YOU MAY HAVE MISSED
Biotech & Genetic Research
Unlocking Precision Genomics: Bio-Rad Releases Comprehensive Guide Bundle on the Evolution and Application of Digital PCR
Jia Lissa Oct 22, 2026
Advanced Materials Science
Revolutionary Laser Phase Plate Breakthrough Empowers Electron Microscopes to Image Previously Invisible Cellular Structures and Small Human Proteins
Nila Kartika Wati Oct 22, 2026
Stem Cell & Regenerative Medicine
Beyond Telomeres: Penn Medicine Researchers Discover Unexpected Muscle-Repairing Role for Chromosome Protein TRF2
Dwi Wanna Oct 22, 2026
Laboratory Automation & Robotics
The FDA plans its third rare disease policy change in just over a year
Lana Keisha Oct 22, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ